Gisselbaek Consulting
Senior medical leadership when the next decision matters.
In brief
What does Gisselbaek Consulting do?
Gisselbaek Consulting is a Denmark-based life-science consultancy led by physician executive Mogens Gisselbaek. It provides senior medical leadership, clinical development strategy, Medical Affairs support, senior medical review and independent medical due diligence.
- Who it supports
- Biotech, medtech and specialty-pharma leadership teams, investors, boards and recruitment or interim-management partners.
- When to engage
- When an important clinical, medical, evidence, governance or organisational decision requires experienced senior judgement and practical ownership.
- Geographic coverage
- Denmark, the Nordics, Europe and the UK, with engagement models ranging from focused projects to fractional or interim leadership.
For biotech, medtech and specialty-pharma organisations, investors and boards across the Nordics, Europe and the UK.
Gisselbaek Consulting provides fractional and interim medical leadership, clinical development strategy, Medical Affairs support and independent medical due diligence when clinical, medical, evidence or organisational decisions require senior judgement.
Choose the route that best matches your situation.
For companies and leadership teams
Need senior medical support, consultancy, review, interim leadership or project-based advisory input?
For recruitment and interim partners
Have a client assignment that may require senior medical leadership on a fractional, interim, advisory or project basis?
Who we help
We support CEOs and executive teams, global and affiliate Medical Affairs leaders, investors and boards, and recruitment or interim-management partners. Engagements can be fractional, interim or focused on a defined project or decision point. Assignments can also incorporate mentoring and capability building where strengthening the internal medical or scientific team is part of the objective.
Typical situations
- A biotech needs CMO-level ownership before a full-time hire is justified.
- A clinical programme, evidence package or next study needs to be made decision-ready and investable.
- A company is preparing for launch, geographic expansion or a Medical Affairs build-out.
- An investor, board or executive team needs an independent medical and clinical perspective before a material decision.
- A medical-scientific team needs senior mentoring, role clarity or stronger capability.
Short interview
A short introduction to Gisselbaek Consulting
Listen to a brief introduction to Gisselbaek Consulting and the five areas where senior medical support can help organisations make better decisions, strengthen business value and support better outcomes for patients.
Episode 1
Introduction to Gisselbaek Consulting
Five ways senior medical support can create value
A brief introduction to Gisselbaek Consulting and the five service areas explored in the series.
Duration: 2:36
Ready to play.
Current consulting collaboration
In May 2026, Gisselbaek Consulting began a fractional consulting assignment with Abacus Medicine Pharmaceuticals, established in collaboration with Brice Group.
Structured around approximately two to three days per week, the engagement combines senior Medical Affairs and medical-strategy input with hands-on execution.
Credibility snapshot
Physician executive with 20+ years in pharma, biotech, medtech and medical devices after eight years of clinical practice. Former CMO, Nordic Medical Director and Senior Director in global clinical development.
Based in Denmark and working across the Nordics, Europe and the UK, Gisselbaek Consulting combines experience from global pharma, biotech, medtech and specialty-care settings.
Not sure where to start?
If the type of support is still unclear, start with the navigator. It will help identify the decision in front of you and a practical starting point for senior medical support.